Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness‐to‐Pay Approach

OBJECTIVE: To investigate willingness to pay (WTP) for treatment with infliximab by patients with ankylosing spondylitis (AS) and explore factors associated with WTP. METHODS: Data from 85 patients participating in the European AS Infliximab Cohort (EASIC) open‐label extension of the AS Study for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Webers, Casper, Essers, Ivette, van Tubergen, Astrid, Braun, Jürgen, Heldmann, Frank, Baraliakos, Xenofon, Boonen, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Ankylosing Spondylitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901401/
https://www.ncbi.nlm.nih.gov/pubmed/28575536
http://dx.doi.org/10.1002/acr.23299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901401/
https://www.ncbi.nlm.nih.gov/pubmed/28575536
http://dx.doi.org/10.1002/acr.23299

Ejemplares similares